Objective. to evaluate the long-term clinical and radiological outcome of matrix-assisted autologous chondrocyte implantation (maCi) for articular cartilage defects in the knee joint. Design. Clinical evaluation was assessed in 21 patients with full-thickness cartilage defects, international Cartilage repair Society (iCrS) grade iV. Clinical scoring was performed preoperatively and 12 years after transplantation using the international Knee Documentation Committee (iKDC) score, the lysholm score, the Knee injury and Osteoarthritis Outcome Score (KOOS), and the Noyes sports activity rating scale. Morphologic evaluation of the repair tissue was assessed by magnetic resonance imaging (Mri) in 14 patients using the Kreuz-Henderson score. Results. Clinical evaluation revealed significant improvement in the iKDC, the lysholm, the KOOS, and the Noyes score. Morphological evaluation by Mri showed moderate to complete defect filling in 10 of 14 patients, demonstrating normal to nearly normal values in mean 74.29% of all assessed parameters. Significant correlation of the parameter cartilage signal and clinical outcome was found with the iKDC, lysholm, and KOOS subscales aDl (activities of daily living) and Qol (quality of life). Conclusions. the clinical and radiological outcomes 12 years after transplantation suggest the confirmation of the promising results of the mid-term follow-up. this study therefore provides first indications that the implantation of maCi might be a suitable option for long-term cartilage repair. Future controlled studies need to address the exact parameters influencing the long-term outcome of maCi.
Introduction
In the developing progress of articular cartilage repair, autologous chondrocyte implantation (ACI) has become a first-line treatment for large chondral defects. 1 Although first-generation ACI (pACI) has been well-documented, substantial knowledge about the long-term progression of third-generation mACI is rare.
In the past decades, different types of matrices for mACI have been developed. 2 In mACI based on a fibrin-polymer graft, autologous in vitro expanded chondrocytes are 3-dimensionally rearranged in a bioresorbable polymer scaffold that allows arthroscopic implantation. 3 Clinical and radiological evaluation showed significant improvement in clinical outcome and joint function as well as satisfactory defect filling by magnetic resonance imaging (MRI) analysis in short-term 4 and mid-term 5 follow-up. Similar results were also achieved in an osteoarthritis subgroup at 4 years after transplantation. 6 These clinical findings demonstrate the efficacy and reliability of the transplant for ACI, suggesting it as an effective treatment option for the regeneration of posttraumatic and/or osteoarthritic defects of the knee.
In this study, we show the long-term clinical and radiological outcome of mACI for the treatment of focal articular cartilage defects of the knee by clinical, functional, and MRI evaluation.
Materials and Methods

Patients
From December 2001 to December 2003, 79 patients were treated with mACI for their symptomatic shouldered, focal, posttraumatic, or degenerative cartilage defects in the knee with International Cartilage Repair Society (ICRS) classification IV. 7 Short-term (n = 20) 4 to midterm (n = 52) 5 follow-up of this patient population reporting clinical and MRI results as well as 4-year follow-up of the osteoarthritis subgroup (n = 19) 6 have been published previously.
In this study, 21 patients gave consent to clinical followup at 12 years after transplantation and 14 patients allowed structural evaluation by MRI analysis. Clinical evaluation was carried out by comparison of the situation documented preoperatively and 12 years after surgery by clinical scores and MRI assessment.
Characteristics of the study population can be seen in Table 1 . Femoral or high tibial osteotomies were indicated with varus or valgus malalignments >5° after investigation of axial deformities by radiographs of the entire leg.
Surgical implantation and Follow-up treatment
Isolation of autologous chondrocytes, cell expansion, and implantation of BioSeed-C (BioTissue Technologies GmbH, Freiburg, Germany) has been performed as described previously. [4] [5] [6] In brief, approximately 250 mg of healthy cartilage tissue were harvested from a nonweightbearing zone of the knee joint by a first arthroscopic procedure and chondrocytes were isolated and in vitro expanded under GMP conditions. A polymer-based scaffold consisting of polyglycolic/polylactic acid (polyglactin, Vicryl, and polydioxanone [Ethicon GmbH, Norderstedt, Germany]) was used for 3-dimensional arrangement of autologous chondrocytes with fibrin gluing. After debridement of the defects, the autologous chondrocyte grafts were adjusted to the defect size and fixed by transosseous anchoring technique. [3] [4] [5] [6] Rehabilitation started on the first day after surgery. Patients were mobilized on crutches and subjected to continuous passive motion as described previously [4] [5] [6] 8 ( Table 2) .
evaluation of Clinical and Radiological Results
Clinical and functional outcome was evaluated by the International Knee Documentation Committee (IKDC) score, 9 the Lysholm score, 10 the Knee injury and Ostheoarthritis Outcome (KOOS) score, 11 and the Noyes sports activity rating scale. 12 Visualization of the knee joint by MRI has been investigated in a 1.5-T MRI scanner (Siemens, Erlangen, Germany) and the data were evaluated using the Henderson and Kreuz scoring system (Table 3) . 13, 14 The analysis of the images was blinded and performed by a clinician and an independent musculoskeletal radiologist, who has not been involved in the initial study.
For structural evaluation of the repair tissue, a 1.5-T MRI (Avanto, Siemens, Erlangen, Germany) with a dedicated 8-channel-knee-coil was used with following sequences: Fast spin-echo proton-density weighted (repetition time/ echo time [TR/TE] 2810/31 ms) in coronal and sagittal plane, Fast spin-echo proton-density weighted with spectral fat saturation (TR/TE 3370/36 ms) in transversal, coronal and sagittal plane, Fast spin-echo T2-weighted with spectral fat-saturation (TR/TE 5880/60 ms) in sagittal plane, The spatial resolution in plane was 320 × 320 up to 512 × 512 pixels in a field-of-view of 1002 mm.
Statistical Analysis
For statistical analysis of the clinical outcome, the Kolmogorov-Smirnov method was applied for testing normal distribution of data with SigmaStat 3.5 software (Systat Software Inc, San Jose, CA, USA). Normal distributed data of IKDC and KOOS subscales Symptom and Quality of Life were analyzed by the parametric Student t test. Differences were considered significant at P < 0.05. Nonparametric data of KOOS, Lysholm, and Noyes scores were analyzed by Mann-Whitney rank sum test, considering differences significant at P < 0.05.
For analysis of correlation between clinical scores and MRI parameters, the Pearson product moment test was used, correlation was considered significant at P < 0.05.
Results
Clinical evaluation
In 21 patients, the IKDC score showed highly significant improvement (P ≤ 0.001) at 12 years postoperatively compared with patients' preoperative situation, increasing from a mean 46.92 ± 13.63 to 71.15 ± 16.56 (Fig. 1) .
Twelve years after transplantation, clinical evaluation determined by the Lysholm score in 21 patients showed an increase of median 56 to 86, therefore significant improvement (P ≤ 0.001) compared with the preoperative situation (Fig. 2) .
Evaluation of the clinical and functional outcome in 19 patients assessed by the KOOS score revealed significant improvement in the subscales Pain, Activities of Daily Living (ADL), Sports and Recreation (Sport/Rec), and Quality of Life (QoL) (P ≤ 0.001). Subscales increased in mean scores Pain from 63. (Fig. 3) .
Further functional analysis in 21 patients determined by the Noyes score revealed a median increase from 20 to 75 indicating a significant increase in sports activities (P ≤ 0.001) (Fig. 4) .
Magnetic Resonance imaging and evaluation
After assessment of clinical and functional outcome, 14 patients gave consent to further structural evaluation by MRI (Table 3) . MRI data of remaining 7 patients could not be acquired due to limited compliance and participation.
Images analyzed by the Henderson and Kreuz scoring system showed normal to abnormal defect filling 12 years after transplantation. Eight of 14 patients presented with complete filling of the defect, in 2 patients the defect was filled less than 50% (Fig. 5) . Four patients showed fullthickness cartilage defects and no defect filling. 10 patients showed no or mild (≤150%) hypertrophy presenting normal or nearly normal cartilage signal. In 7 patients, the defects showed normal cartilage signal whereas three patients presented with slight areas of hyperintensity. All patients showed no or only mild subchondral edema. Mild bone marrow edema was evident in 10 patients and absent in 4 patients. Ten to 13 years after transplantation, 10 patients showed no or mild effusion, whereas moderate to severe effusion was evident in 4 patients. In overall MRI analysis, normal or nearly normal values were present in average 74.29% of all subcategories, whereas moderate or abnormal values could be found in mean 25.71% (Fig. 6) .
Analysis of the correlation between MRI parameters and clinical scores revealed significant correlation between the cartilage signal and the IKDC (r = −0.544, P = 0.0441), Lysholm (r = −0.537, P = 0.0479), KOOS ADL (r = −0.596, P = 0.0244), and KOOS QoL (r = −0.546, P = 0.0434).
Discussion
In this study, we showed for the first time a 12-year clinical and radiological outcome of mACI for the treatment of focal articular cartilage defects of the knee joint. Clinical evaluation showed significant improvement in all assessed scores compared with the preoperative situation. Detailed analysis of the current data compared with the mid-term follow-up results 5 showed no significant changes in all clinical scores, thus proving persistent results in patient satisfaction, function and activity. This is in line with previous findings demonstrating the maintenance of good clinical mid-term results even up to 10 to 20 years after pACI transplantation. [15] [16] [17] High levels of physical activity as measured in the Noyes sports activity rating scale additionally correspond with previous findings, that physical training improves the long-term outcome after ACI treatment. 18 Apparently, although clinical assessment revealed significant changes in IKDC, Lysholm, Noyes, and in the KOOS subscales Pain, ADL, Sports/Rec, and QoL, the patients estimated no change in the subscale Symptom, a subscale focusing on the subjective perception of stiffness, grinding and motion. Similar effects on the KOOS subscale Symptom in case of long-term clinical outcome of mACI have already been observed previously (see below). 19 Nevertheless, further analysis of the significant improvements KOOS subscales Pain, ADL, Sport/Rec and QoL at 12 years after transplantation compared to the preoperative situation exceed a minimal perceptible clinical improvement (MPCI) that can be considered not only as statistically significant but also as clinically relevant. 20 Different studies describe the long-term clinical outcome of the use of pACI reporting of significant improvement in IKDC, Lysholm, Tegner, and KOOS score, 17, [21] [22] [23] whereas studies investigating the long-term results of mACI are rare. Ten-year follow-up results with a hyaluronic acid-based scaffold correspond with our findings, indicating significant improvement in the IKDC, Noyes and KOOS subscales Pain and QoL. Investigation of KOOS Symptom, ADL, and Sport/ Rec as well as Tegner, Brittberg, and VAS showed no significant differences compared with the preoperative situation. In addition, the authors stated a slight downward tendency of all clinical scores in long-term progression. 19 Clinical followup at 15 years postoperatively based on a collagen membrane showed significant improvement in the Lysholm, IKDC and Tegner score. 24 However, this study is limited to subjective scores and no morphological analysis by MRI is provided.
Comparison of the clinical results of the current study to mid-term follow-up suggests long-term durability of mACI in case of clinical outcome and function since no significant differences could be detected, including IKDC (P = 0.151), Lysholm (P = 0.251), KOOS Pain (P = 1.0), KOOS Symptom (P = 0.151), KOOS ADL (P = 0.41), KOOS Sport/Rec (P = 0.681), KOOS QoL (P = 0.722), and Noyes (P = 0.215) (data not shown). 5, 6 Regarding morphological analysis by MRI, we could show the presence of normal to nearly normal values in 74.29% according to the Henderson-Kreuz scoring system. This is in line with previous findings, demonstrating ACI as a long-term solution in more than 70% of affected patients. 25 Complete defect filling could be observed in 57% of all cases. Full-thickness cartilage defects were evident in 4 cases; however, 3 of these cases were located retropatellar. After complete defect filling at 4 years after transplantation 5 , these patients subsequently experienced the loss of their transplant during the following years. This corresponds with previous findings, since retropatellar lesions were reported to lead to inferior results and were associated with higher rates of complications in the use of both ACI 14, 16, 26 and microfracture. 27 Since other authors state excellent results in retropatellar cartilage repair, 21, 28 pACI might be considered as a successful approach, however, it still remains challenging regarding the particular biomechanical environment of the localization. 28 Altogether, evaluation of the long-term outcome of mACI for retropatellar defects requires further data.
In the present study, subchondral edema was evident in 71% of the patients. This is in line with other investigators reporting persistent subchondral edema in up to more than 80% in first-generation pACI 21, 22 and in mACI. 19 Although bone marrow edema could be identified as a possible prognostic factor of clinical outcome and knee function, 29 subchondral edema showed no correlation with the clinical results in this study, demonstrating that the incidence of bone marrow edema still remains controversial. 30 MRI has widely been described as a noninvasive method suitable for cartilage repair tissue monitoring in short and mid-terms. [31] [32] [33] [34] However, in terms of long-term progression, deteriorating correlation of MRI parameters has been frequently observed. 19, 21, 31, 35 Poor correlation therefore might be interpreted as possible degenerative progression and/or unrelated knee injury or dysfunction. 31 The trend of deteriorating MRI parameters along with stable clinical outcomes consequently challenges the potential of MRI for the longterm repair tissue monitoring. 21, 31 However, compared with previous findings of the long-term outcome of matrixassisted ACI, we could still demonstrate significant correlation of the cartilage signal with the IKDC, Lysholm, and KOOS subscales ADL and QoL. This is in line with a comprehensive analysis, identifying graft hypertrophy and repair tissue signal as the critical parameters in the correlation of MRI with clinical outcome after ACI. 31 Nevertheless, the current results are based on a relatively small follow-up cohort. Therefore, the role of MRI in long-term monitoring still remains unclear and requires further investigation.
Although histological analysis of BioSeed-C by secondlook arthroscopy assessed in patients of the same population in short-term follow up showed complete filling, good integration, and formation of hyaline-like repair tissue, 4 the lack of histological evaluation is a limitation of this study.
A further limitation is the heterogeneous composition of the study population, comprehending different concomitant surgical procedures such as femoral or high tibial osteotomy, ACL reconstruction or microfracture/drilling of secondary lesions. Although possibly influencing the final results, the different approaches can be considered as a necessary intervention to provide uniform biomechanical requirements and comparable loading of the defect area. 5, 36 Altogether, these patients of the current study population represent cases in daily practice.
The study population 12 years after surgery involved a reduced follow-up rate due to limited patient participation and compliance as found to be associated with patient recruitment over long-term follow-up periods. 19, 23, 24 However, the extent of the current study population is equivalent to the previous studies of long-term matrixassisted ACI. 19, 24 During the past years, different studies have been reporting successful long-term outcome of pACI as a cartilage repair procedure. Follow-up of minimum 10 years showed survivorship of the repair site in 71% of the treated patients together with improved function in 75% 37 and satisfactory survival rates corresponding to significant clinical improvements could be reported up to 20 years after surgery. 38 Although first-generation ACI has been that well documented, substantial knowledge about the long-term progression of matrix-assisted ACI is still missing. 39 The reexamined patients of the current study presented with significant improvement in patient satisfaction, clinical outcome, and function 12 years after transplantation and the morphological evaluation by MRI revealed normal to nearly normal values in more than 70%. The consistency of the data acquired at 4 years postoperatively together with a persistent correlation between MRI parameters and clinical outcomes might suggest the long-term durability of the transplant. Together with a thorough reference to the mentioned limitations, this study provides first indications that the implantation of mACI might be a suitable option for long-term cartilage repair.
Future controlled clinical studies have to elucidate the exact conditions influencing the long-term outcome and the appropriate parameters for long-term MRI monitoring of matrix-assisted ACI for the treatment of focal articular cartilage defects of the knee joint.
